Who
Vicky Hahne
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Celcuity.
In numbers
- Trades disclosed
- 41
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Jul 2018
- Last trade
- 14 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 18 Aug 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code A | —16,000 at $0.00 | filing |
| 18 Aug 2025filed 20 Aug 2025 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,328 at $0.00 | filing |
| 20 Aug 2024filed 26 Aug 2024 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 20 Aug 2024filed 22 Aug 2024 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 13 Feb 2024filed 15 Feb 2024 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,530 at $0.00 | filing |
| 25 Aug 2023filed 29 Aug 2023 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,250 at $0.00 | filing |
| 25 Aug 2023filed 29 Aug 2023 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 16 Feb 2023filed 21 Feb 2023 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,069 at $0.00 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code D | —3,000 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code D | —932 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —932 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code D | —3,000 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,122 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,122 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.